| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-10 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |